Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate effects on dopaminergic brain development in adolescent and adult males with ADHD
NL-OMON20266Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Methylphenidate with Placebo (2 arms). Primary endpoints: phMRI response to acute methylphenidate challenge, Diffusion tensor imaging measures and 1 more. Started Jun 2011; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON20266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20266.